Taşkın DUMAN, Murat GÜNTEL, Özcan DEMETGÜL

The effect of initial complaints and third year MRI lesion load on EDSS of multiple sclerosis patients

Aim: We aimed to investigate the effect of initial complaints and third-year MRI lesion burden on Expanded Disability Status Scale (EDSS) of Multiple Sclerosis Patients.Materials and Methods: Patients who were admitted to the Mustafa Kemal University Faculty of Medicine Neurology clinic and diagnosed with Multiple Sclerosis according to Mc Donald diagnostic criteria were included in the study. The initial symptoms of patients, MRI lesion burden at the end of the third year, and the EDSS score were recorded retrospectively from the patient files. 74.5 % of the participants were female and 25.5 % were male. The most common initial symptoms were: Sensory symptoms, vision symptoms, pyramidal tract symptoms, and polysymptomatic. The mean age of the patients was 33.4. Mean EDSS was found to be 1.8±1.3. The total number of lesions in the brain was 14.8 ± 4.83 on average.Results: If patients compared according to the initial symptoms at the end of the third year, the highest EDSS score was at the polysymptomatic onset group, the second-highest score was at the motor onset group. The patients with the initial symptoms of motor or polysymptomatic group had a higher mean EDSS score than the patients with the initial symptoms of vision, sensorial symptoms, or cranial neuropathy. When we examine the relationship between MRI lesion load at the end of the third year and the EDSS score, there is a strong positive correlation between them. Patients who have more lesions in the brain on MRI studies have higher average EDSS scores than patients who have fewer lesions in the brain.Conclusion: We found that the initial symptoms are directly related to the third-year EDSS score and the prognosis of the disease. We found that there was a significant relationship between the number of lesions in the brain on MRI studies at the end of the third year and the mean EDSS score.

PDF

___

1. Katz Sand IB, Lublin FD. Diagnosis and differential diagnosis of multiple sclerosis. Continuum. 2013;19:922-43.
2. Meyer-Moock S, Feng YS, Maeurer M, et al. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol 2014;14:1471-2377.
3. Baranzini SE, Elfstrom C, Chang SY, et al. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J Immunol 2000;165:6576-82.
4. Hemond CC, Bakshi R. Magnetic resonance imaging in multiple sclerosis. Cold Spring Harb Perspect Med 2018;8(5).
5. Newcombe J, Hawkins CP, Henderson CL, et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain : a J Neurol 1991;114:1013-23.
6. Briggs FBS, Thompson NR, Conway DS. Prognostic factors of disability in relapsing remitting multiple sclerosis. Mult Scler Relat Disord 2019;30:9-16.
7. Louapre C, Bodini B, Lubetzki C, Freeman L, Stankoff B. Imaging markers of multiple sclerosis prognosis. Curr Opin Neurol 2017;30:231-6.
8. Siva A. Common Clinical and imaging conditions misdiagnosed as multiple sclerosis: a current approach to the differential diagnosis of multiple sclerosis. Neurol Clin 2018;36:69-117.
9. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of neurology 2001;50:121-7.
10. Vukusic S, Confavreux C. Natural history of multiple sclerosis. Presse Med 2010;39:359-62.
11. Ebers GC. Natural history of primary progressive multiple sclerosis. Mult Scler 2004;10:S8- 13;discussion S-5.
12. McDonnell GV, Hawkins SA. Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J Neurol Sci 2002;199:1-15.
13. Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain : J Neurol 1999;122:625-39.
14. Sailer M, O'Riordan JI, Thompson AJ, et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology 1999;52:599- 606.
15. Grimaud J, Barker GJ, Wang L, et al. Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study. Journal of neurology. 1999;246:961-7.
16. Ammitzbøll C, Dyrby TB, Lyksborg M, et al. Disability in progressive MS is associated with T2 lesion changes. Mult Scler Relat Disord 2018;20:73-7.
17. Filippi M, Mastronardo G, Rocca MA, et al. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 1998;158:148-53.
18. Comi G, Filippi M, Rovaris M, et al. Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry. 1998;64:S21-5.
19. Paz Soldán MM, Raman MR, Gamez JD, et al. Correlation of brain atrophy, disability, and spinal cord atrophy in a murine model of multiple sclerosis. J Neuroimaging 2015;25:595-9.
20. Harrison DM, Roy S, Oh J, et al. Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol 2015;72:1004-12.